US President Donald Trump on Friday announced a fresh slew of tariffs, including a 100 per cent tariff on “branded or patented pharmaceutical products.” The only exemption is for companies that are building plants in the US.

Representatives from the industry have said that this is unlikely to affect the Indian industry, which largely exports generic drugs to the US. Yet, it has led to confusion and panic among the country’s drug manufacturers.

The confusion — what does the US mean by branded drugs?

Without an executive order on the new tariffs announced by President Trump in a Truth Social post, the Indian industry is currently confused about what would be considered branded drugs.

“When it comes to patented drugs, the definition is clear. A tariff on patented drugs would affect prod

See Full Page